Skip to main content
. Author manuscript; available in PMC: 2011 Feb 19.
Published in final edited form as: Am J Psychiatry. 2009 Nov 2;166(12):1347–1354. doi: 10.1176/appi.ajp.2009.09030345

Table 1. Pre-treatment Characteristics by Treatment Group and Site.

Wait-List Self-Help Therapist-Assisted Therapist-Led Total Sample
(MN=31/ND=38/Total=69) (MN=15/ND=52/Total=67) (MN=18/ND=45/Total=63) (MN=37/ND=23/Total=60) (MN=101/ND=158/Total=259)

Age
(mean ± SD)
MN: 49.3 ± 8.4 MN: 52.1 ± 8.3 MN: 50.3 ± 9.1 MN: 50.3 ± 9.1 MN: 52.1 ± 8.3
ND: 46.2 ± 12.0 ND: 45.6 ± 10.6 ND: 47.2 ± 9.0 ND: 47.2 ± 9.0 ND: 45.6 ± 10.6
Total: 47.6 ± 10.6 Total: 47.1 ± 10.4 Total: 48.1 ± 9.1 Total: 48.1 ± 9.1 Total: 47.1 ± 10.4

Females
(n, %)
MN: 23 (74.2%) MN: 15 (100%) MN: 13 (72.2%) MN: 37 (100%) MN: 88 (87.1%)
ND: 33 (86.8%) ND: 45 (86.5%) ND: 38 (84.4%) ND: 23 (100%) ND: 139 (88.0%)
Total: 56 (81.2%) Total: 60 (89.6%) Total: 51 (81.0%) Total: 60 (100%) Total: 227 (87.6%)

Caucasian
(n, %)
MN: 29 (93.5%) MN: 15 (100%) MN: 18 (100%) MN: 33 (89.2%) MN: 95 (94.1%)
ND: 38 (100%) ND: 52 (100%) ND: 42 (93.3%) ND: 22 (95.7%) ND: 154 (97.5%)
Total: 67 (97.1%) Total: 67 (100%) Total: 60 (95.2%) Total: 55 (91.7%) Total: 249 (96.1%)

Antidepressant Medication
(n, %)
MN: 25 (80.6%) MN: 12 (80.0%) MN: 14 (77.8%) MN: 33 (89.2%) MN: 80 (79.2%)
ND: 28 (73.7%) ND: 43 (82.7%) ND: 36 (86.0%) ND: 22 (95.7%) ND: 124 (78.5%)
Total: 53 (76.8%) Total: 55 (82.1%) Total: 50 (79.4%) Total: 55 (91.7%) Total: 204 (78.8%)

BMI
(mean ± SD)
MN: 39.8 ± 7.7 MN: 35.9 ± 7.7 MN: 39.7 ± 9.1 MN: 37.9 ± 8.3 MN: 38.5 ± 8.2
ND: 36.7 ± 5.9 ND: 38.8 ± 7.0 ND: 41.1 ± 8.7 ND: 41.3 ± 8.2 ND: 39.3 ± 7.6
Total: 38.1 ± 6.9 Total: 38.2 ± 7.2 Total: 40.7 ± 8.8 Total: 39.2 ± 8.3 Total: 39.0 ± 7.8

Objective Binge Days
(mean ± SD)
MN: 16.9 ± 8.0 MN: 16.2 ± 6.9 MN: 16.6 ± 7.1 MN: 17.0 ± 6.7 MN: 16.8 ± 7.1
ND: 17.3 ± 6.4 ND: 16.4 ± 6.9 ND: 16.3 ± 6.3 ND: 14.2 ± 7.0 ND: 16.3 ± 6.6
Total: 17.1 ± 7.1 Total: 16.4 ± 6.8 Total: 16.4 ± 6.5 Total: 16.0 ± 6.9 Total: 16.5 ± 6.8

Objective Binge Episodes
(mean ± SD)
MN: 22.8 ± 16.1 MN: 18.5 ± 10.4 MN: 22.2 ± 15.3 MN: 27.4 ± 21.2 MN: 23.7 ± 17.4
ND: 23.5 ± 12.3 ND: 23.5 ± 14.4 ND: 21.8 ± 11.2 ND: 20.0 ± 13.2 ND: 22.5 ± 12.8
Total: 23.1 ± 14.1 Total: 22.4 ± 13.7 Total: 21.9 ± 12.3 Total: 24.6 ± 18.7 Total: 23.0 ± 14.8

EDE Restraint
(mean ± SD)
MN: 1.4 ± 1.3 MN: 1.9 ± 1.7 MN: 1.4 ± 1.1 MN: 1.8 ± 1.4 MN: 1.6 ± 1.4
ND: 1.5 ± 1.2 ND: 1.7 ± 1.4 ND: 1.3 ± 1.1 ND: 1.4 ± 1.1 ND: 1.5 ± 1.2
Total: 1.5 ± 1.2 Total: 1.8 ± 1.5 Total: 1.3 ± 1.1 Total: 1.6 ± 1.3 Total: 1.5 ± 1.3

EDE Eating Concerns
(mean ± SD)
MN: 1.7 ± 1.2 MN: 2.4 ± 1.1 MN: 1.8 ± 1.3 MN: 2.4 ± 1.1 MN: 2.1 ± 1.2
ND: 1.8 ± 1.4 ND: 1.8 ± 1.3 ND: 1.9 ± 1.2 ND: 1.6 ± 1.1 ND: 1.8 ± 1.3
Total: 1.8 ± 1.3 Total: 1.9 ± 1.3 Total: 1.9 ± 1.2 Total: 2.1 ± 1.2 Total: 1.9 ± 1.3

EDE Shape Concerns
(mean ± SD)
MN: 3.4 ± 1.1 MN: 3.9 ± 0.8 MN: 3.2 ± 1.1 MN: 4.0 ± 0.9 MN: 3.7 ± 1.0
ND: 3.8 ± 1.1 ND: 3.6 ± 1.2 ND: 3.2 ± 1.0 ND: 3.4 ± 0.7 ND: 3.5 ± 1.0
Total: 3.6 ± 1.1 Total: 3.7 ± 1.1 Total: 3.2 ± 1.0 Total: 3.8 ± 0.8 Total: 3.6 ± 1.0

EDE Weight Concerns
(mean ± SD)
MN: 3.1 ± 0.9 MN: 3.5 ± 1.0 MN: 3.1 ± 1.1 MN: 3.9 ± 1.0 MN: 3.4 ± 1.0
ND: 3.6 ± 1.1 ND: 3.4 ± 1.1 ND: 3.0 ± 1.2 ND: 3.4 ± 1.1 ND: 3.3 ± 1.1
Total: 3.4 ± 1.0 Total: 3.4 ± 1.1 Total: 3.0 ± 1.2 Total: 3.7 ± 1.0 Total: 3.4 ± 1.1

EDE Global
(mean ± SD)
MN: 2.4 ± 0.8 MN: 2.9 ± 0.9 MN: 2.4 ± 0.8 MN: 3.0 ± 0.7 MN: 2.7 ± 0.8
ND: 2.7 ± 0.9 ND: 2.6 ± 0.9 ND: 2.4 ± 0.8 ND: 2.5 ± 0.8 ND: 2.6 ± 0.9
Total: 2.6 ± 0.9 Total: 2.7 ± 0.9 Total: 2.4 ± 0.8 Total: 2.8 ± 0.8 Total: 2.6 ± 0.9

IDS-SR
(mean ± SD)
MN: 26.8 ± 12.9 MN: 28.1 ± 11.9 MN: 21.9 ± 11.1 MN: 26.0 ± 10.4 MN: 25.8 ± 11.5
ND: 26.0 ± 11.8 ND: 26.2 ± 11.0 ND: 19.8 ± 9.6 ND: 24.0 ± 11.8 ND: 24.0 ± 11.2
Total: 26.4 ± 12.2 Total: 26.7 ± 11.2 Total: 20.4 ± 10.0 Total: 25.2 ± 10.9 Total: 24.7 ± 11.3

TFEQ Restraint
(mean ± SD)
MN: 7.2 ± 3.4 MN: 8.6 ± 4.1 MN: 7.2 ± 3.3 MN: 7.7 ± 3.3 MN: 7.6 ± 3.4
ND: 6.6 ± 3.0 ND: 6.2 ± 3.9 ND: 6.0 ± 3.4 ND: 5.3 ± 2.9 ND: 6.1 ± 3.4
Total: 6.9 ± 3.2 Total: 6.8 ± 4.1 Total: 6.4 ± 3.4 Total: 6.8 ± 3.3 Total: 6.7 ± 3.5

TFEQ Disinhibition
(mean ± SD)
MN: 13.5 ± 2.0 MN: 14.0 ± 1.6 MN: 13.7 ± 1.5 MN: 14.5 ± 1.4 MN: 14.0 ± 1.7
ND: 13.7 ± 2.0 ND: 13.7 ± 1.7 ND: 13.5 ± 2.0 ND: 13.9 ± 1.7 ND: 13.7 ± 1.9
Total: 13.6 ± 2.0 Total: 13.8 ± 1.7 Total: 13.6 ± 1.9 Total: 14.3 ± 1.5 Total: 13.8 ± 1.8

TFEQ Hunger
(mean ± SD)
MN: 9.1 ± 3.6 MN: 10.2 ± 3.6 MN: 10.1 ± 2.7 MN: 9.3 ± 3.4 MN: 9.5 ± 3.3
ND: 9.5 ± 3.6 ND: 10.4 ± 2.9 ND: 9.7 ± 3.1 ND: 9.9 ± 3.1 ND: 9.9 ± 3.2
Total: 9.3 ± 3.5 Total: 10.4 ± 3.1 Total: 9.8 ± 3.0 Total: 9.5 ± 3.3 Total: 9.8 ± 3.2

IWQOL-Lite Total
(mean ± SD)
MN: 56.9 ± 21.7 MN: 55.3 ± 26.7 MN: 52.5 ± 22.8 MN: 54.4 ± 16.5 MN: 55.0 ± 20.8
ND: 53.1 ± 14.1 ND: 52.6 ± 19.4 ND: 51.7 ± 19.3 ND: 51.6 ± 19.4 ND: 52.3 ± 18.3
Total: 55.3 ± 18.7 Total: 53.3 ± 21.4 Total: 52.0 ± 20.3 Total: 53.4 ± 17.5 Total: 53.5 ± 19.4

Rosenberg Self-Esteem
(mean ± SD)
MN: 2.6 ± 1.9 MN: 2.8 ± 2.3 MN: 1.9 ± 1.8 MN: 2.5 ± 1.9 MN: 2.5 ± 1.9
ND: 3.1 ± 2.0 ND: 3.3 ± 2.0 ND: 2.5 ± 2.0 ND: 2.7 ± 1.9 ND: 2.9 ± 2.0
Total: 2.8 ± 2.0 Total: 3.2 ± 2.1 Total: 2.3 ± 1.9 Total: 2.6 ± 1.9 Total: 2.7 ± 2.0

p = .014 for main effect of site (MN > ND)

p = .003 for main effect of treatment group (TL > WL,TA)

p = .001 for main effect of site (MN > ND)